Page 441 - Read Online

Yang et al. Hepatoma Res 2020;6:37 I http://dx.doi.org/10.20517/2394-5079.2020.09 Page 13 of 13

splenectomy and esophagogastric devascularization. J Thromb Thrombolysis 2015;40:294-301.
98. Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011;365:147-56.
99. Lenz K, Dieplinger B, Buder R, Piringer P, Rauch M, et al. Successful treatment of partial portal vein thrombosis (PVT) with low dose
rivaroxaban. Z Gastroenterol 2014;52:1175-7.
100. Yang H, Kim SR, Song MJ. Recurrent acute portal vein thrombosis in liver cirrhosis treated by rivaroxaban. Clin Mol Hepatol
2016;22:499-502.
101. Potze W, Arshad F, Adelmeijer J, Blokzijl H, van den Berg AP, et al. Differential in vitro inhibition of thrombin generation by
anticoagulant drugs in plasma from patients with cirrhosis. PLoS One 2014;9:e88390.
102. Artaza T, Lopes M, Romero M, Gomez AZ, de la Cruz G, et al. Efficacy and safety of anticoagulation in non-malignant portal vein
thrombosis in patients with liver cirrhosis. Gastroenterol Hepatol 2018;41:611-7.
103. Qi X, Han G, Wang J, Wu K, Fan D. Degree of portal vein thrombosis. Hepatology 2010;51:1089-90.
104. Senzolo M, M Sartori T, Rossetto V, Burra P, Cillo U, et al. Prospective evaluation of anticoagulation and transjugular intrahepatic
portosystemic shunt for the management of portal vein thrombosis in cirrhosis. Liver Int 2012;32:919-27.
105. Gaba RC, Parvinian A. Transjugular intrahepatic portosystemic shunt for maintenance of portal venous patency in liver transplant
candidates. J Clin Imaging Sci 2013;3:28.
106. Lakhoo J, Gaba RC. Outcomes of transjugular intrahepatic portosystemic shunt creation for flow-enabled dissolution of spleno-
mesenterico-portal venous thrombosis. Diagn Interv Imaging 2016;97:1085-93.
107. Riggio O, Ridola L, Lucidi C, Angeloni S. Emerging issues in the use of transjugular intrahepatic portosystemic shunt (TIPS) for
management of portal hypertension: time to update the guidelines? Dig Liver Dis 2010;42:462-7.
108. Inagaki Y, Sugimoto K, Shiraki K, Tameda M, Kusagawa S, et al. The long-term effects of splenectomy and subsequent interferon therapy
in patients with HCV-related liver cirrhosis. Mol Med Rep 2014;9:487-92.
109. Yang S, He C, Fan X, Ding W, Wu X, et al. Early prophylactic anticoagulation via transjugular intrahepatic route for portal vein
thrombosis after splenectomy in cirrhotic portal hypertension. J Vasc Interv Radiol 2015;26:1009-17.
110. Shang CZ, Chen YJ, Zhang HW, Zhang L, Cao J, et al. Splenic autotransplantation combined with lower esophagus transaction in the
treatment of hepatic cirrhosis induced portal hypertension. Zhonghua Wai Ke Za Zhi 2009;47:83-5. (in Chinese)
111. Shan HJ, Ji-Sheng C, Zhuo W, Rufu C, Zhihao Z, et al. Portal veinous hemodynamics after subtotal splenectomy and portaazygous
devascularization. Zhongguo Putong Waike Zazhi 2010;25:20-3.
112. Zhu Y. Analysis of 26 cases of autotransplantation of spleen tissue after splenectomy. Clin Med Chin 2004;20:459-60. (in Chinese)